ES2179867T3 - Entrecruzamientos de piridinolina como marcadores de actividad de enfermedad periodontal o peri-implante. - Google Patents

Entrecruzamientos de piridinolina como marcadores de actividad de enfermedad periodontal o peri-implante.

Info

Publication number
ES2179867T3
ES2179867T3 ES95909234T ES95909234T ES2179867T3 ES 2179867 T3 ES2179867 T3 ES 2179867T3 ES 95909234 T ES95909234 T ES 95909234T ES 95909234 T ES95909234 T ES 95909234T ES 2179867 T3 ES2179867 T3 ES 2179867T3
Authority
ES
Spain
Prior art keywords
peri
periodontal
piridinoline
training
activity markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95909234T
Other languages
English (en)
Inventor
William V Giannobile
Samuel E Lynch
Ray C Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Institute of Molecular Biology Inc
Original Assignee
Harvard College
Institute of Molecular Biology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Institute of Molecular Biology Inc filed Critical Harvard College
Application granted granted Critical
Publication of ES2179867T3 publication Critical patent/ES2179867T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/146666—Bile pigment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)

Abstract

SE PRESENTA UN METODO PARA DIAGNOSTICAR LA SEVERIDAD DE UNA ENFERMEDAD PERIODONTAL O DE UNA ENFERMEDAD PERI-IMPLANTE EN UN PACIENTE HUMANO, QUE COMPRENDE A) OBTENER UNA MUESTRA DE TEJIDO CREVICULAR GINGIVAL U OTRO FLUIDO DE LA BOCA DEL PACIENTE, O UNA MUESTRA DE SANGRE U ORINA DEL PACIENTE, Y B) MEDIR EL ENLACE DE PIRIDINOLINA EN LA MUESTRA COMO MEDIDA DE LA SEVERIDAD DE LA ENFERMEDAD.
ES95909234T 1994-02-16 1995-01-13 Entrecruzamientos de piridinolina como marcadores de actividad de enfermedad periodontal o peri-implante. Expired - Lifetime ES2179867T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/197,131 US5516699A (en) 1994-02-16 1994-02-16 Pyridinoline crosslinks as markers of periodontal and peri-implant disease activity

Publications (1)

Publication Number Publication Date
ES2179867T3 true ES2179867T3 (es) 2003-02-01

Family

ID=22728172

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95909234T Expired - Lifetime ES2179867T3 (es) 1994-02-16 1995-01-13 Entrecruzamientos de piridinolina como marcadores de actividad de enfermedad periodontal o peri-implante.

Country Status (13)

Country Link
US (1) US5516699A (es)
EP (1) EP0745221B1 (es)
JP (1) JP3521913B2 (es)
KR (1) KR970701349A (es)
CN (1) CN1145116A (es)
AT (1) ATE220458T1 (es)
AU (1) AU1726495A (es)
CA (1) CA2183452C (es)
DE (1) DE69527350T2 (es)
DK (1) DK0745221T3 (es)
ES (1) ES2179867T3 (es)
PT (1) PT745221E (es)
WO (1) WO1995022763A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
JP6871855B2 (ja) 2014-10-14 2021-05-19 サムエル リンチ， 創傷を処置するための組成物
EP3477306A1 (en) * 2017-10-30 2019-05-01 Koninklijke Philips N.V. Classification of periodontitis patients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735945A (en) * 1986-03-13 1988-04-05 Vipont Laboratories, Inc. Method for inhibiting bone resorption and collagenase release
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase

Also Published As

Publication number Publication date
US5516699A (en) 1996-05-14
ATE220458T1 (de) 2002-07-15
CA2183452A1 (en) 1995-08-24
DK0745221T3 (da) 2002-11-04
CN1145116A (zh) 1997-03-12
EP0745221A4 (en) 1998-06-10
KR970701349A (ko) 1997-03-17
JP3521913B2 (ja) 2004-04-26
EP0745221B1 (en) 2002-07-10
EP0745221A1 (en) 1996-12-04
PT745221E (pt) 2002-11-29
DE69527350T2 (de) 2003-03-13
AU1726495A (en) 1995-09-04
WO1995022763A1 (en) 1995-08-24
JPH09509486A (ja) 1997-09-22
CA2183452C (en) 2007-03-27
DE69527350D1 (de) 2002-08-14

Similar Documents

Publication Publication Date Title
EP1099102A4 (en) TRACE DETECTION OF ANALYTES BY ARTIFICIAL OLFAKTOMETRY
DE60025526D1 (de) Elisa für vegf
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
DE69635174D1 (de) Nichtinvasive Vorrichtung zur Blutuntersuchung
ATE189957T1 (de) Verwendung von nadph-oxidase-inhibitoren zur herstellung eines arzneimittels zur vorbeugung der arteriosklerose
AU1726797A (en) A method for monitoring the health of a patient by measuring and predicting the glucose level of the patient's blood sample
ES2160709T3 (es) Uso de lipocalina de neutrofilos humanos (hnl) como un marcador de diagnostico y preparacion de anticuerpo anti-hnl.
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
DE69527916D1 (de) Nicht-invasive Vorrichtung zur Blut-Analyse
DK0931264T3 (da) Fremgangsmåde til diagnosticering af aterosklerose
DK0931265T3 (da) Diagnistisk metode for aterosklerose
DE69527366D1 (de) Enzymatische zusammensetzung fur die klinische untersuchung
DE60140862D1 (de) Nichtinvasives gerät zur diagnose von krankheiten
ES2179867T3 (es) Entrecruzamientos de piridinolina como marcadores de actividad de enfermedad periodontal o peri-implante.
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
DE69624782D1 (de) Elektrodenzuleitung für implantierbare medizinische Vorrichtung, insbesondere für Herzschrittmacher
DK250888D0 (da) Praeparat og kit til anvendelse ved diagnosticering af periodontalsygdomme
DE69612628D1 (de) Implantierbare, medizinische vorrichtung zur analyse von herzrythmusabweichungen
ATE554790T1 (de) Verfahren und zusammensetzungen zur diagnose von asthma
RU93039981A (ru) Способ оценки выраженности воспалительного процесса в тканях пародонта
DE69725333D1 (de) Verfahren zur bestimmung eines erhöhten sterblichkeitsrate
IT1276615B1 (it) Metodo per la rivelazione di catecolamine durante il ritmo circadiano, uso di detto metodo per la diagnosi e la terapia di malattie nervose
DK16995A (da) Middel til analyse af fysiologisk dannet HCG's eliminering hos en human patient, fremgangsmåde til en vitro-måling af HCG-omsætning i patienter med forhøjet HCG-niveau samt anvendelse af et sådant middel
RU95108626A (ru) Способ диагностики замедленного биологического развития детей